MINT, INSERM U1066, CNRS 6021, University of Angers, SFR-ICAT 4208, Angers, 49933, France.
CHU Angers, Pharmacy department, 49933, Angers, France.
Nanomedicine (Lond). 2024;19(13):1123-1131. doi: 10.2217/nnm-2024-0003. Epub 2024 Sep 20.
The present study investigated renal elimination after intravenous administration of four different formulations of lipid nanocapsules (LNCs) containing dyes adapted to Förster resonance energy transfer (FRET-LNCs). FRET-LNCs of 85 or 50 nm with or without a pegylated surface were injected and collected in the blood or urine of rats at different time points. Quantitative analysis was performed to measure intact FRET-LNCs. No intact LNCs were found in urine (0 particles/ml) for all formulations. The 50-nm pegylated LNCs were eliminated faster from the blood, whereas 85-nm pegylated LNCS were eliminated slower than nonpegylated LNCs. Elimination of FRET-LNCs was mainly due to liver tissue interaction and not renal elimination.
本研究考察了静脉注射四种不同配方的载染料脂质纳米胶囊(LNC)后的肾清除情况,这些 LNC 适用于Förster 共振能量转移(FRET-LNC)。85nm 或 50nm 的 FRET-LNC 具有或不具有聚乙二醇化表面,在不同时间点注入并收集在大鼠的血液或尿液中。定量分析用于测量完整的 FRET-LNC。对于所有制剂,尿液中均未发现完整的 LNC(0 个颗粒/ml)。50nm 的聚乙二醇化 LNC 从血液中更快地清除,而 85nm 的聚乙二醇化 LNC 比非聚乙二醇化 LNC 清除得更慢。FRET-LNC 的清除主要归因于肝组织相互作用,而不是肾清除。